Is this you? Create Your Porfile
Avatar

David Kenneth GlaxoSmithKline Dean

University of California, Berkeley

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where David Kenneth GlaxoSmithKline Dean is active.

Explore More

Publication

Featured researches published by David Kenneth GlaxoSmithKline Dean.

Archive | 2001

Imidazole-2-carboxamide derivatives as raf kinase inhibitors

David Kenneth GlaxoSmithKline Dean; Andrew Kenneth Glaxosmithkline Takle; David M. Wilson

Archive | 2003

Benzo d!azepine derivatives for the treatment of neurological disorders

Mark James GlaxoSmithKline Bamford; David Kenneth GlaxoSmithKline Dean; Sanjeet Singh Sehmi; David Matthew Wilson; Jason GlaxoSmithKline Witherington

Archive | 2001

Imidazole derivatives as raf kinase inhibitors

David Kenneth GlaxoSmithKline Dean; Andrew Kenneth Glaxosmithkline Takle; David M. Wilson

Archive | 2004

Benzazepine derivatives as histamine h3 antagonists

Nicholas GlaxoSmithKline Bailey; Mark James GlaxoSmithKline Bamford; David Kenneth GlaxoSmithKline Dean; Paula Louise GlaxoSmithKline Pickering; David Matthew Wilson; Jason GlaxoSmithKline Witherington

Archive | 2004

4- (4-(heterocyclylalkoxy}phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer’s

Mark James GlaxoSmithKline Bamford; David Kenneth GlaxoSmithKline Dean; David Matthew Wilson

Archive | 2002

Pyridine derivatives as raf kinase inhibitors

Mark J. Bamford; David Kenneth GlaxoSmithKline Dean; Antoinette Naylor; Andrew Kenneth Glaxosmithkline Takle; David M. Wilson

Archive | 2007

N- (phenylmethyl) -2- (1h-pyraz0l-4-yl) acetamide derivatives as p2x7 antagonists for the treatment of pain, inflammation and neurodegeneration

Paul John Beswick; Laura Jane Chambers; David John Davies; David Kenneth GlaxoSmithKline Dean; Emmanuel Hubert Demont; Susan Roomans; Daryl Simon Walter

Archive | 2005

Piperazine Derivatives Useful for the Treatment of Gastrointestinal Disorders

Alessandra Gaiba; Nigel Paul King; Andrew Kenneth Glaxosmithkline Takle; Jason GlaxoSmithKline Witherington; David Kenneth GlaxoSmithKline Dean

Archive | 2002

Pyridylfurans and pyrroles as raf kinase inhibitors

David Kenneth GlaxoSmithKline Dean; Andrew Kenneth Glaxosmithkline Takle; David M. Wilson

Archive | 2002

Pyridine substituted furan derivatives as raf kinase inhibitors

David Kenneth GlaxoSmithKline Dean; Andrew Kenneth Glaxosmithkline Takle; David M. Wilson

Explore More

Collaboration

Dive into the David Kenneth GlaxoSmithKline Dean's collaboration.

Top Co-Authors
Avatar

Andrew Kenneth Glaxosmithkline Takle

University of California

View shared research outputs
Top Co-Authors
Avatar

David M. Wilson

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Jason GlaxoSmithKline Witherington

University of California

View shared research outputs
Top Co-Authors
Avatar

David Matthew Wilson

University of California

View shared research outputs
Top Co-Authors
Avatar

Daryl Simon Walter

University of California

View shared research outputs
Top Co-Authors
Avatar

Mark James Bamford

University of California

View shared research outputs
Top Co-Authors
Avatar

Mark James GlaxoSmithKline Bamford

University of California

View shared research outputs
Top Co-Authors
Avatar

Mark J. Bamford

GlaxoSmithKline

View shared research outputs
Top Co-Authors
Avatar

Laura Jane Chambers

University of California

View shared research outputs
Top Co-Authors
Avatar

Paul John Beswick

University of California

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge